FDA Approves First Generic of Xofluza for Influenza Treatment
The FDA has approved the first generic version of Xofluza, a single-dose treatment for influenza.
Therapeutic Area
Therapeutic area intelligence for Influenza with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.